World's Best Scientists 2026 revealed!

D-Index & Metrics

Neuroscience

D-Index
49
Citations
9463
World Ranking
5954
National Ranking
2609

David Feifel publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where David Feifel sits on this spectrum.

38–47 publications: 18 scientists 48–57 publications: 79 scientists 58–67 publications: 193 scientists 68–77 publications: 323 scientists 78–87 publications: 406 scientists 88–97 publications: 452 scientists 98–107 publications: 539 scientists 108–117 publications: 505 scientists 118–127 publications: 522 scientists 128–137 publications: 469 scientists 138–147 publications: 456 scientists 148–157 publications: 459 scientists 158–167 publications: 397 scientists 168–177 publications: 383 scientists 178–187 publications: 350 scientists 188–197 publications: 302 scientists 198–207 publications: 306 scientists 208–217 publications: 262 scientists 218–227 publications: 242 scientists 228–237 publications: 220 scientists 238–247 publications: 203 scientists 248–257 publications: 174 scientists 258–267 publications: 176 scientists 268–277 publications: 175 scientists 278–287 publications: 125 scientists 288–297 publications: 116 scientists 298–307 publications: 127 scientists 308–317 publications: 128 scientists 318–327 publications: 99 scientists 328–337 publications: 89 scientists 338–347 publications: 78 scientists 348–357 publications: 96 scientists 358–367 publications: 66 scientists 368–377 publications: 59 scientists 378–387 publications: 65 scientists 388–397 publications: 54 scientists 398–407 publications: 48 scientists 408–417 publications: 49 scientists 418–427 publications: 34 scientists 428–437 publications: 31 scientists 438–447 publications: 30 scientists 448–457 publications: 31 scientists 458–467 publications: 36 scientists 468–477 publications: 40 scientists 478–487 publications: 35 scientists 488–497 publications: 30 scientists 498–507 publications: 23 scientists 508–517 publications: 26 scientists 518–527 publications: 20 scientists 528–537 publications: 23 scientists 538–547 publications: 20 scientists 548–557 publications: 20 scientists 558–567 publications: 17 scientists 568–577 publications: 14 scientists 578–587 publications: 20 scientists 588–597 publications: 20 scientists 598–607 publications: 19 scientists 608–617 publications: 18 scientists 618–627 publications: 17 scientists 628–637 publications: 11 scientists 638–647 publications: 11 scientists 648–657 publications: 11 scientists 658–667 publications: 8 scientists 668–677 publications: 7 scientists 678–687 publications: 11 scientists 688–697 publications: 10 scientists 698–707 publications: 4 scientists 708–717 publications: 6 scientists 718–727 publications: 5 scientists 728–737 publications: 5 scientists 738–747 publications: 9 scientists 748–757 publications: 9 scientists 758–767 publications: 3 scientists 768–777 publications: 7 scientists 778–787 publications: 7 scientists 788–797 publications: 6 scientists 798–807 publications: 2 scientists 808–817 publications: 2 scientists 818–827 publications: 7 scientists 828–837 publications: 0 scientists 838–847 publications: 9 scientists 848–857 publications: 3 scientists 858–867 publications: 1 scientists 868–877 publications: 3 scientists 878–886 publications: 6 scientists 887+ publications: 100 scientists
38 publications 887+

This scientist: 164 publications — 49th percentile

49% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 887 publications or more.

David Feifel D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where David Feifel sits on this spectrum.

30–31 D-Index: 42 scientists 32–33 D-Index: 172 scientists 34–35 D-Index: 296 scientists 36–37 D-Index: 435 scientists 38–39 D-Index: 459 scientists 40–41 D-Index: 456 scientists 42–43 D-Index: 467 scientists 44–45 D-Index: 478 scientists 46–47 D-Index: 512 scientists 48–49 D-Index: 435 scientists 50–51 D-Index: 425 scientists 52–53 D-Index: 418 scientists 54–55 D-Index: 392 scientists 56–57 D-Index: 357 scientists 58–59 D-Index: 334 scientists 60–61 D-Index: 328 scientists 62–63 D-Index: 260 scientists 64–65 D-Index: 278 scientists 66–67 D-Index: 239 scientists 68–69 D-Index: 250 scientists 70–71 D-Index: 210 scientists 72–73 D-Index: 200 scientists 74–75 D-Index: 189 scientists 76–77 D-Index: 170 scientists 78–79 D-Index: 146 scientists 80–81 D-Index: 113 scientists 82–83 D-Index: 126 scientists 84–85 D-Index: 100 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 99 scientists 90–91 D-Index: 84 scientists 92–93 D-Index: 85 scientists 94–95 D-Index: 72 scientists 96–97 D-Index: 76 scientists 98–99 D-Index: 45 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 43 scientists 104–105 D-Index: 32 scientists 106–107 D-Index: 45 scientists 108–109 D-Index: 50 scientists 110–111 D-Index: 32 scientists 112–113 D-Index: 39 scientists 114–115 D-Index: 32 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 27 scientists 120–121 D-Index: 19 scientists 122–123 D-Index: 23 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 16 scientists 128–129 D-Index: 24 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 21 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 14 scientists 138–139 D-Index: 15 scientists 140–141 D-Index: 10 scientists 142–143 D-Index: 10 scientists 144–145 D-Index: 13 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 8 scientists 150–151 D-Index: 6 scientists 152–153 D-Index: 6 scientists 154–155 D-Index: 7 scientists 156–157 D-Index: 7 scientists 158–159 D-Index: 10 scientists 160–161 D-Index: 4 scientists 162 D-Index: 8 scientists 163+ D-Index: 100 scientists
30 D-Index 163+

This scientist: 49 D-Index — 39th percentile

39% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 163 D-Index or more.

Overview

David Feifel is affiliated with the University of California, San Diego in the United States. Their research spans multiple fields, primarily focusing on psychology, medicine, and neuroscience. Within these areas, Feifel has contributed notably to subfields including neurology, social psychology, clinical psychology, experimental and cognitive psychology, and organic chemistry.

Feifel's work centers on several main topics, such as neuroendocrine regulation and behavior, transcranial magnetic stimulation studies, evolutionary psychology and human behavior, psychedelics and drug studies, chemical synthesis and alkaloids, treatment of major depression, and functional brain connectivity studies.

Key recent papers authored or coauthored by Feifel include:

  • Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression (2022, New England Journal of Medicine)
  • Repetitive transcranial magnetic stimulation for smoking cessation: a pivotal multicenter double-blind randomized controlled trial (2021, World Psychiatry)
  • Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life (2023, Journal of Affective Disorders)
  • Psilocybin for treatment resistant depression in patients taking a concomitant SSRI medication (2023, Neuropsychopharmacology)
  • Deep Transcranial Magnetic Stimulation Combined With Brief Exposure for Posttraumatic Stress Disorder: A Prospective Multisite Randomized Trial (2021, Biological Psychiatry)

Frequent coauthors collaborating with Feifel include Tian Lin, Natalie C. Ebner, Guy M. Goodwin, Boadie W. Dunlop, and David J. Hellerstein.

The preferred publication venues for Feifel's research include:

  • Journal of Affective Disorders
  • Brain Stimulation
  • Biological Psychiatry
  • New England Journal of Medicine
  • World Psychiatry

Best Publications

  • Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.

    Unknown

  • A systematic review of modafinil: Potential clinical uses and mechanisms of action.

    Jacob S. Ballon;David Feifel

  • Efficacy and Safety of Deep Transcranial Magnetic Stimulation for Obsessive-Compulsive Disorder: A Prospective Multicenter Randomized Double-Blind Placebo-Controlled Trial.

    Lior Carmi;Aron Tendler;Alexander Bystritsky;Eric Hollander

  • Adjunctive intranasal oxytocin reduces symptoms in schizophrenia patients.

    David Feifel;Kai Macdonald;Angel Nguyen;Patrice Cobb

  • Sensorimotor gating deficits in bipolar disorder patients with acute psychotic mania

    William Perry;Arpi Minassian;Arpi Minassian;David Feifel;David L Braff

  • Attitudes Toward Psychiatry as a Prospective Career Among Students Entering Medical School

    David Feifel;Christine Yu Moutier;Neal R. Swerdlow

  • Repetitive transcranial magnetic stimulation for smoking cessation: a pivotal multicenter double-blind randomized controlled trial

    Abraham Zangen;Hagar Moshe;Diana Martinez;Noam Barnea-Ygael

  • Helping oxytocin deliver: considerations in the development of oxytocin-based therapeutics for brain disorders

    Kai Macdonald;David Feifel

  • Acute treatment of psychotic agitation: a randomized comparison of oral treatment with risperidone and lorazepam versus intramuscular treatment with haloperidol and lorazepam.

    Glenn W. Currier;James C.-Y. Chou;David Feifel;Cynthia A. Bossie

  • Rapid acute treatment of agitation in individuals with schizophrenia: multicentre, randomised, placebo-controlled study of inhaled loxapine.

    Michael D. Lesem;Tram K. Tran-Johnson;Robert A. Riesenberg;David Feifel

  • Extended release quetiapine fumarate monotherapy in major depressive disorder: a placebo- and duloxetine-controlled study.

    Andrew J. Cutler;Stuart A. Montgomery;David Feifel;Arthur Lazarus

  • Oxytocin and psychotherapy: a pilot study of its physiological, behavioral and subjective effects in males with depression.

    Kai MacDonald;Tina Marie MacDonald;Martin Brüne;Kristi Lamb

  • The effect of intranasal oxytocin treatment on conditioned fear extinction and recall in a healthy human sample.

    Dean T. Acheson;David Feifel;Sofieke de Wilde;Rebecca Mckinney

  • Oxytocin's role in anxiety: a critical appraisal.

    Kai MacDonald;David Feifel

  • Oxytocin modulates psychotomimetic-induced deficits in sensorimotor gating.

    D. Feifel;Tammi Reza

  • Adjunctive intranasal oxytocin improves verbal memory in people with schizophrenia.

    David Feifel;Kai MacDonald;Patrice Cobb;Arpi Minassian

  • Psilocybin for treatment resistant depression in patients taking a concomitant SSRI medication

    Unknown

  • Oxytocin in schizophrenia: a review of evidence for its therapeutic effects

    Kai MacDonald;David Feifel

  • Efficacy and Safety of Low-field Synchronized Transcranial Magnetic Stimulation (sTMS) for Treatment of Major Depression

    Andrew F. Leuchter;Ian A. Cook;David Feifel;John W. Goethe

  • Inhibitory deficits in ocular motor behavior in adults with attention-deficit/hyperactivity disorder

    David Feifel;Robert H. Farber;Brett A. Clementz;William Perry

  • Efficacy and Safety of Loxapine for Inhalation in the Treatment of Agitation in Patients With Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Trial

    Michael H. Allen;David Feifel;Michael D. Lesem;Daniel L. Zimbroff

  • Novel Antipsychotic-Like Effects on Prepulse Inhibition of Startle Produced by a Neurotensin Agonist

    David Feifel;Tammi L. Reza;David J. Wustrow;M. Duff Davis

  • A Review of Oxytocin’s Effects on the Positive, Negative, and Cognitive Domains of Schizophrenia

    David Feifel;Paul D. Shilling;Kai MacDonald

  • ATTENTION-DEFICIT HYPERACTIVITY DISORDER IN ADULTS

    David Feifel

Frequent Co-Authors

William Perry
William Perry University of California, San Diego
Arpi Minassian
Arpi Minassian University of California, San Diego
Håkan Fischer
Håkan Fischer Stockholm University
Mark S. George
Mark S. George Medical University of South Carolina
Neal R. Swerdlow
Neal R. Swerdlow University of California, San Diego
Abraham Zangen
Abraham Zangen Ben-Gurion University of the Negev
Ronald A. Cohen
Ronald A. Cohen University of Florida
Dan V. Iosifescu
Dan V. Iosifescu New York University
Daniel Z. Press
Daniel Z. Press Harvard Medical School
Victoria B. Risbrough
Victoria B. Risbrough University of California, San Diego

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

A degree in neuroscience opens doors to various career paths beyond traditional research. Many students interested in brain science, mental health, or counseling choose to expand their qualifications through related online degrees. If you are passionate about therapy and family dynamics, consider marriage and family therapy master's programs. These programs focus on supporting families and couples, and can lead to licensed clinical work.

Those curious about broader aspects of behavior and mental processes may explore online psychology masters or entry-level psychology degrees. Psychology is a versatile field that covers topics from cognitive science to organizational behavior and offers diverse career options in counseling, education, or business.

Additionally, if your interests lie in social impact and community work, an online master's in social work may be valuable. This degree prepares graduates for roles in advocacy, case management, and therapy, complementing neuroscience expertise with practical skills to help individuals navigate life challenges. Choosing the right pathway can enhance your career and make a meaningful difference in various settings.

Best Scientists Citing David Feifel

Trending Scientists

Recently Published Articles